Lonza Group (CHIX:LONNZ) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:LONNZ Lonza Group Ltd CHIX:LONNZ
86 GF Score
Price CHF558.80
GF Value CHF582.02
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Lonza Group FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:LONNZ
86GF Score
Lonza Group Ltd CHIX:LONNZ
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lonza Group (CHIX:LONNZ) Overvalued in 2026?

Based on GuruFocus' analysis, Lonza Group stock appears to be undervalued. The current stock price of CHF558.80 is trading 4% below its estimated GF Value™ of CHF582.02. GuruFocus considers Lonza Group to be Fairly Valued.

Key valuation signals for CHIX:LONNZ:

  • FFO:
  • GF Value™: CHF582.02 vs. price of CHF558.80 (4% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the CHIX:LONNZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lonza Group Business Description

Address Muenchensteinerstrasse 38, Basel, CHE, 4002
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
86GF Score

Get the complete analysis for CHIX:LONNZ

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF558.80
Price
CHF582.02
GF Value